Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02251834 · ClinicalTrials.gov registry record · NA

Hispanic Secondary Stroke Prevention Initiative

A NA study, sponsored by University of Miami.

Completed
Registry status
NA
Development phase
200
Enrollment target

NCT02251834: Completed NA study, sponsored by University of Miami.

NCT02251834 is a NA study that has completed, run by University of Miami. The registered enrollment target is 200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02251834, a NA study, has completed, sponsored by University of Miami.

COMPLETED
Registry status
NA
Development phase
200 participants
Enrollment target

Study Summary

Stroke is a leading cause of death and functional impairments and stroke risk factors (SRFs) disproportionately affect Latino populations. In the Hispanic Secondary Stroke Prevention Initiative (HISSPI) the investigators propose a study using Community Health Workers (CHW) and mobile technologies using cell phones to reduce the risk for a recurrent stroke among Latino stroke patients. The project examines the effectiveness of a combined multilevel intervention consisting of Community Health Workers (CHW) and mobile based phone technologies in lowering of systolic blood pressure (SBP) which is the most important risk factor for recurrent stroke.

Primary Outcome

Our primary hypothesis is that at twelve months, patients in the intervention arm will have SBP on average, 8mmHg lower than those in the control group.

Interventions

  • BEHAVIORAL Community Health Worker (CHW)
  • OTHER usual care and health education brochures every 4 months.

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2015-01
Est. Completion 2019-06-18
Phase NA
University of Miami

721 total trials

What the finished NCT02251834 record still lists

NCT02251834 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).

The record links to 0 conditions, and to 2 interventions - of which Community Health Worker (CHW) is the first listed.

NCT02251834 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02251834 about?

NCT02251834 is a clinical study titled "Hispanic Secondary Stroke Prevention Initiative". Stroke is a leading cause of death and functional impairments and stroke risk factors (SRFs) disproportionately affect Latino populations. In the Hispanic Secondary Stroke Prevention Initiative (HISSPI) the investigators propose a study using Community Health Workers (CHW) and mobile technologies us...

What is the current status of trial NCT02251834?

This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2015-01. Estimated completion is 2019-06-18.

What interventions are being tested in trial NCT02251834?

The interventions under investigation include: Community Health Worker (CHW) (BEHAVIORAL), usual care and health education brochures every 4 months. (OTHER).

Who is sponsoring clinical trial NCT02251834?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02251834's enrollment target sits among peer trials

200 506th of 2000 higher than 1,434 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02251834, the US trial registry maintained by the National Library of Medicine. NCT02251834 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.